scRNA-seq data showed that BCL2A1+macrophages in tumor and normal tissues had highly similar expression of macrophage marker genes (such as CD68 and CD163) (Fig. 5A–B), indicating consistent fundamental macrophage characteristics. This evidence concerns the gene CD163 and neoplasm.